{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:01:21Z","timestamp":1789182081750,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830113"],"award-info":[{"award-number":["81830113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2019B030302005"],"award-info":[{"award-number":["2019B030302005"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1704200"],"award-info":[{"award-number":["2018YFC1704200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.biopha.2022.112696","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:56:23Z","timestamp":1644972983000},"page":"112696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214 \/ SIRT3 signaling pathway"],"prefix":"10.1016","volume":"148","author":[{"given":"Yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaju","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglu","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.112696_bib1","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biopha.2022.112696_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.105.569491","article-title":"Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the losartan intervention for endpoint reduction in hypertension (LIFE) study","volume":"113","author":"Okin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2022.112696_bib3","doi-asserted-by":"crossref","unstructured":"G.D. Couto, M. Ouzounian, P.P. Liu, Early detection of myocardial dysfunction and heart failure. Nature Reviews Cardiology. \u3008https:\/\/doi.org\/10.1038\/nrcardio.2010.51\u3009.","DOI":"10.1038\/nrcardio.2010.51"},{"key":"10.1016\/j.biopha.2022.112696_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2022.112696_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112696_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1479-5876-12-47","article-title":"The Chinese herbal medicine FTZ attenuates insulin resistance via IRS1 and PI3K in vitro and in rats with metabolic syndrome","volume":"12","author":"Hu","year":"2014","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.biopha.2022.112696_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jep.2011.03.012","article-title":"A new TCM formula FTZ lowers serum cholesterol by regulating HMG-CoA reductase and CYP7A1 in hyperlipidemic rats","volume":"135","author":"Jiao","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2022.112696_bib8","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2018.3844","article-title":"Cardioprotective effects and underlying mechanism of Radix Salvia miltiorrhiza and Lignum Dalbergia odorifera in a pig chronic myocardial ischemia model","author":"Lin","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2022.112696_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.21010\/ajtcam.v13i4.20","article-title":"Salvianolic acid b alleviating myocardium injury in ischemia reperfusion rats","volume":"13","author":"Qiao","year":"2016","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"issue":"8","key":"10.1016\/j.biopha.2022.112696_bib10","first-page":"1285","article-title":"The effect of fufang zhenzhu tiaozhi capsule on lipid metabolism in atherosclerotic rabbits","volume":"33","author":"Tang","year":"2010","journal-title":"J. Chin. Med. Mater."},{"key":"10.1016\/j.biopha.2022.112696_bib11","article-title":"Liver hypolipidemic protection of Compound Zhenzhu Tiaozhi Capsula on nonalcoholic fatty liver disease in rats and its mechanism","author":"Yao","year":"2011","journal-title":"Chin. Tradit. Herb. Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2022.112696_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-018-0921-3","article-title":"Fufang-Zhenzhu-Tiaozhi Capsule reduces restenosis via the downregulation of NF-\u03baB and inflammatory factors in rabbits","volume":"17","author":"Zhang","year":"2018","journal-title":"Lipids Health Dis."},{"issue":"4","key":"10.1016\/j.biopha.2022.112696_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ng865","article-title":"Micro RNAs are complementary to 3\u2032 UTR sequence motifs that mediate negative post-transcriptional regulation","volume":"30","author":"Lai","year":"2002","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.biopha.2022.112696_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ncb0309-228","article-title":"Many roads to maturity: microRNA biogenesis pathways and their regulation","volume":"11","author":"Diederichs","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2022.112696_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.vph.2011.08.001","article-title":"microRNAs as peripheral blood biomarkers of cardiovascular disease","volume":"55","author":"Stefano","year":"2011","journal-title":"Vasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2022.112696_bib16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2012.01.030","article-title":"Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma","volume":"418","author":"Kinoshita","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2022.112696_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/CIRCULATIONAHA.110.012237","article-title":"Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection","volume":"124","author":"Li","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2022.112696_bib18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.RES.0000257913.42552.23","article-title":"MicroRNAs play an essential role in the development of cardiac hypertrophy","volume":"100","author":"Sayed","year":"2007","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.biopha.2022.112696_bib19","doi-asserted-by":"crossref","DOI":"10.1152\/physiolgenomics.00145.2010","article-title":"MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats","volume":"43","author":"Soci","year":"2011","journal-title":"Physiol. Genom."},{"issue":"2","key":"10.1016\/j.biopha.2022.112696_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jss.2014.06.044","article-title":"Cardiac hypertrophy and dysfunction induced by overexpression of miR-214 in vivo","volume":"192","author":"Yang","year":"2014","journal-title":"J. Surg. Res."},{"issue":"4","key":"10.1016\/j.biopha.2022.112696_bib21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.bbrc.2013.05.079","article-title":"MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2","volume":"436","author":"Yang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2022.112696_bib22","first-page":"2758","article-title":"Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice","volume":"119","author":"Sundaresan","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2022.112696_bib23","doi-asserted-by":"crossref","unstructured":"Y.Q. Ding, Y.H. Zhang, J. Lu et al., MicroRNA-214 contributes to Ang \u2161-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction. Acta Pharmacologica Sinica. \u3008https:\/\/doi.org\/10.1038\/s41401\u2013020-00563\u20137\u3009.","DOI":"10.1038\/s41401-020-00563-7"},{"issue":"8","key":"10.1016\/j.biopha.2022.112696_bib24","article-title":"NLRP3 inflammasome formation and activation in non-alcoholic steatohepatitis: therapeutic target for antimetabolic syndrome remedy FTZ","volume":"2018","author":"Yu","year":"2018","journal-title":"Oxid.\u00a0Med.\u00a0Cell.\u00a0Longev."},{"key":"10.1016\/j.biopha.2022.112696_bib25","article-title":"Gut microbiota combined with metabolomics reveals the metabolic profile of the normal aging process and the anti-aging effect of FuFang Zhenshu TiaoZhi(FTZ) in mice","volume":"121","author":"Duosheng","year":"2019","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.biopha.2022.112696_bib26","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCRESAHA.115.306624","article-title":"miR-206 mediates YAP-induced cardiac hypertrophy and survival","volume":"117","author":"Yang","year":"2015","journal-title":"Circ. Res."},{"issue":"23","key":"10.1016\/j.biopha.2022.112696_bib27","first-page":"5462","article-title":"MiR-181a mediates Ang \u2161-induced myocardial hypertrophy by mediating autophagy","volume":"21","author":"Li","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2022.112696_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12967-015-0725-4","article-title":"MicroRNA regulation of unfolded protein response transcription factor XBP1 in the progression of cardiac hypertrophy and heart failure in vivo","volume":"13","author":"Quanlu","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2022.112696_bib29","article-title":"Current state and future perspective of cardiovascular medicines derived from natural products - ScienceDirect","author":"Cz","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2022.112696_bib30","article-title":"The role of biologically active ingredients from Chinese herbal medicines in the regulation of autophagy in treating cardiovascular diseases and other chronic diseases","volume":"23","author":"Xing","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"7","key":"10.1016\/j.biopha.2022.112696_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/6378786","article-title":"Chinese medicine FTZ recipe protects against high-glucose-induced beta cell injury through alleviating oxidative stress","volume":"2019","author":"Bei","year":"2019","journal-title":"Evid. -Based Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2022.112696_bib32","article-title":"FTZ Ameliorates diabetic cardiomyopathy by inhibiting inflammation and cardiac fibrosis in the streptozotocin-induced model","volume":"2021","author":"Wang","year":"2021","journal-title":"Evid. Based Complement Altern. Med"},{"issue":"3","key":"10.1016\/j.biopha.2022.112696_bib33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jjcc.2011.01.009","article-title":"Altered microRNA expression associated with reduced catecholamine sensitivity in patients with chronic heart failure","volume":"57","author":"Funahashi","year":"2011","journal-title":"J. Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112696_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/physiolgenomics.00144.2007","article-title":"Altered microRNA expression in human heart disease","volume":"31","author":"Allen","year":"2007","journal-title":"Physiol. Genom."},{"issue":"3","key":"10.1016\/j.biopha.2022.112696_bib35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2022.112696_bib36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1042\/CS20130787","article-title":"Loss of NOX2 (gp91phox) prevents oxidative stress and progression to advanced heart failure","volume":"127","author":"PARAJULI","year":"2014","journal-title":"Clin. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.112696_bib37","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbadis.2011.11.016","article-title":"Non-histone lysine acetylated proteins in heart failure","volume":"1822","author":"Grillon","year":"2012","journal-title":"Biochim. Et. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.biopha.2022.112696_bib38","first-page":"2758","article-title":"Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice","volume":"119","author":"Sundaresan","year":"2009","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.biopha.2022.112696_bib39","doi-asserted-by":"crossref","DOI":"10.18632\/aging.100252","article-title":"Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy","volume":"2","author":"Hafner","year":"2010","journal-title":"Aging"},{"key":"10.1016\/j.biopha.2022.112696_bib40","first-page":"285","article-title":"Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway","author":"Pillai","year":"2010","journal-title":"J. Biol. Chem."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:39:37Z","timestamp":1781764777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222000841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":40,"alternative-id":["S0753332222000841"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112696","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214 \/ SIRT3 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112696"}}